blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2806868

EP2806868 - ANTIMICROBIAL COMPOSITIONS COMPRISING DGLA, 15-OHEPA AND/OR 15-HETRE AND METHODS OF USE THEREOF [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  11.03.2016
Database last updated on 13.07.2024
Most recent event   Tooltip11.03.2016Withdrawal of applicationpublished on 13.04.2016  [2016/15]
Applicant(s)For all designated states
Dignity Sciences Limited
Trintech Building 3rd Floor
South County Business Park
Leopardstown
Dublin 18 / IE
[2014/49]
Inventor(s)01 / ROWE, Jonathan
c/o Dignity Sciences Limited
3rd Floor, Trintech Building
South County Business Park
Leopardstown
Dublin 18 / IE
02 / COUGHLAN, David
c/o Dignity Sciences Limited
3rd Floor, Leopardstown
Dublin 18 / IE
03 / MANKU, Mehar
c/o Dignity Sciences Limited
3rd Floor, Trintech Building
South Country Business Park
Leopardstown
Dublin 18 / IE
 [2014/49]
Representative(s)Wakerley, Helen Rachael
Reddie & Grose LLP The White Chapel Building
10 Whitechapel High Street
London E1 8QS / GB
[N/P]
Former [2014/49]Wakerley, Helen Rachael
Reddie & Grose LLP
16 Theobalds Road
London WC1X 8PL / GB
Application number, filing date13741302.725.01.2013
WO2013US23201
Priority number, dateUS201261591036P26.01.2012         Original published format: US 201261591036 P
US20121347899023.05.2012         Original published format: US201213478990
[2014/49]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013112876
Date:01.08.2013
Language:EN
[2013/31]
Type: A1 Application with search report 
No.:EP2806868
Date:03.12.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 01.08.2013 takes the place of the publication of the European patent application.
[2014/49]
Search report(s)International search report - published on:US01.08.2013
(Supplementary) European search report - dispatched on:EP28.07.2015
ClassificationIPC:A61K31/20, A61P31/04
[2015/35]
CPC:
A61K9/0014 (EP,US); A61K9/0053 (US); A61K31/202 (EP,US);
A61K31/7036 (EP,US); A61K38/12 (EP,US); A61K45/06 (US);
A61P17/00 (EP); A61P17/02 (EP); A61P17/10 (EP);
A61P31/00 (EP); A61P31/04 (EP); A61P31/10 (EP);
A61P43/00 (EP); Y02A50/30 (EP,US) (-)
C-Set:
A61K31/202, A61K2300/00 (EP,US);
A61K31/7036, A61K2300/00 (US,EP);
A61K38/12, A61K2300/00 (US,EP)
Former IPC [2014/49]A61K31/20
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/49]
Extension statesBA16.06.2014
ME16.06.2014
TitleGerman:ANTIMIKROBIELLE ZUSAMMENSETZUNGEN MIT DGLA, 15-OHEPA UND/ODER 15-HETRE UND VERWENDUNGSVERFAHREN DAFÜR[2014/49]
English:ANTIMICROBIAL COMPOSITIONS COMPRISING DGLA, 15-OHEPA AND/OR 15-HETRE AND METHODS OF USE THEREOF[2014/49]
French:COMPOSITIONS ANTIMICROBIENNES COMPRENANT DGLA, 15-OHEPA ET/OU 15-HETRE ET MÉTHODES D'UTILISATION CELLES-CI[2014/49]
Entry into regional phase16.06.2014National basic fee paid 
16.06.2014Search fee paid 
16.06.2014Designation fee(s) paid 
16.06.2014Examination fee paid 
Examination procedure16.06.2014Examination requested  [2014/49]
17.02.2016Amendment by applicant (claims and/or description)
03.03.2016Application withdrawn by applicant  [2016/15]
Fees paidRenewal fee
13.01.2015Renewal fee patent year 03
11.01.2016Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]US5789441  (GOSSELIN JEAN [CA], et al) [X] 1-5,7,8 * the whole document * * column 5, lines 25-29 * * column 6, line 43 * * column 11, lines 25-32 *;
 [X]US2005239889  (GOSSELIN JEAN [CA], et al) [X] 1-5,7,10 * the whole document * * paragraphs [0014] , [0 48] * * paragraph [0025] *;
 [E]WO2013057284  (DIGNITY SCIENCES LTD [IE]) [E] 1-15 * the whole document *;
 [A]  - HEITMANN J ET AL, "Incorporation of 15-hydroxyeicosatrienoic acid in specific phospholipids of cultured human keratinocytes and psoriatic plaques.", EXPERIMENTAL DERMATOLOGY APR 1995, (199504), vol. 4, no. 2, ISSN 0906-6705, pages 74 - 78, XP055203535 [A] 1 * the whole document *
 [A]  - YUNHI CHO ET AL, "A novel 15-hydroxyeicosatrienoic acid-substituted diacylglycerol (15-HETrE-DAG) selectively inhibits epidermal protein kinase C-[beta]", BIOCHIMICA ET BIOPHYSICA ACTA (BBA) - LIPIDS AND LIPID METABOLISM, (19971101), vol. 1349, no. 1, doi:10.1016/S0005-2760(97)00144-6, ISSN 0005-2760, pages 67 - 71, XP055203537 [A] 1 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0005-2760(97)00144-6
International search[A]US2003073930  (MORRISSEY GERALD R [US], et al);
 [X]US2007015438  (LANGE BETH A [US], et al);
 [Y]WO2007079224  (HE WEI-WU [US], et al);
 [Y]WO2010125340  (EQUATEQ LTD [GB], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.